共 50 条
- [31] Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myelomaBRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 775 - 778Campbell, LaurenPanitsas, FotiosBasu, SupratikAnyanwu, FrancisLee, SophieFerry, BerneRamasamy, Karthik
- [32] Real-World Experience with Minimal Residual Disease Testing with Next Generation Flow Cytometry and Functional Imaging in Multiple MyelomaBLOOD, 2020, 136Bockle, DavidGaviria, Paula TabaresZhou, XiangMesserschmidt, JaninScheller, LukasSteinhardt, Maximilian JohannesSeebacher, ElenaUlbrich, MariaHeidemeier, AnkeBuck, AndreasEinsele, HermannBeilhack, AndreasKortuem, MartinRasche, Leo
- [33] Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based DietsCLINICAL CANCER RESEARCH, 2022, 28 (23) : 5149 - 5155Shah, Urvi A.Maclachlan, Kylee H.Derkach, AndriySalcedo, MeghanBarnett, KellyCaple, JuliaBlaslov, JennaTran, LinhCiardiello, AmandaBurge, MirandaShekarkhand, TalaAdintori, PeterCross, JustinPianko, Matthew J.Hosszu, KingaMcAvoy, DevinMailankody, ShamKorde, NehaHultcrantz, MalinHassoun, HaniTan, Carlyn R.Lu, Sydney X.Patel, DhwaniDiamond, BenjaminShah, GunjanScordo, MichaelLahoud, OscarChung, David J.Landau, HeatherUsmani, Saad Z.Giralt, SergioTaur, YingLandgren, C. OlaBlock, GladysBlock, TorinPeled, Jonathan U.Brink, Marcel R. M. van denLesokhin, Alexander M.
- [34] Sustained minimal residual disease negativity in Multiple Myeloma is impacted positively by stool butyrate and healthier plant forward dietsCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S61 - S61Shah, UrviDerkach, AndriyAdintori, PeterCross, JustinMaclachlan, KyleeMailankody, ShamKorde, NehaHultcrantz, MalinHassoun, HaniTan, CarlynLu, SydneyPatel, DhwaniShah, GunjanScordo, MichaelLahoud, OscarChung, DavidLandau, HeatherGiralt, SergioTaur, YingLandgren, OlaBlock, TorinPeled, Jonathanvan den Brink, MarcelLesokhin, Alexander
- [35] Interphase fish: A simple method for monitoring minimal residual disease in multiple myeloma.BONE MARROW TRANSPLANTATION, 1998, 21 : S181 - S181Dascalescu, CMGarban, FMolina, LChauvet, MCousin, FMarais, DSotto, JJLeroux, D
- [36] Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Patients with Multiple Myeloma Treated with Continuous Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 StudyBLOOD, 2020, 136Diamond, BenjaminKorde, NehaLesokhin, Alexander M.Smith, Eric L.Shah, Urvi A.Mailankody, ShamHultcrantz, MalinHassoun, HaniLu, Sydney X.Tan, CarlynMassey, DonnaSalcedo, MeghanDiab, VictoriaWerner, KellyRispoli, JennaSams, AllisonVerducci, DennisJones, KatieSchlossman, JuliaChansakul, AisaraHarrison, AngelaCiardiello, Amanda KathrynTavitian, ElizabetShekarkhand, TalaPiacentini, CaseyRustad, Even H.Yellapantula, Venkata D.Maura, FrancescoPeterson, Tim J.Derkach, AndriyDevlin, SeanLandau, Heather J.Scordo, MichaelChung, David J.Shah, Gunjan L.Lahoud, Oscar B.Thoren, KatieMurata, KazunoriRamanathan, LakshmiArcila, Maria E.Ho, CalebRoshal, MikhailDogan, AhmetGiralt, Sergio A.Landgren, Ola
- [37] Minimal residual disease (mrd) in multiple myeloma: prognostic and therapeutic implications (including imaging)HEMASPHERE, 2019, 3 : 124 - 126Owen, Roger G.
- [38] The Relevance of Minimal Residual Disease (MRD) Monitoring in Elderly Multiple Myeloma (MM) PatientsBLOOD, 2015, 126 (23)Paiva, BrunoCedena, TeresaPuig, NoemiCordon, LourdesMartinez-Lopez, JoaquinOcio, Enrique M.Hernandez, Miguel T.Isabel Teruel, AnaGironella, MercedesAsuncion Echeveste, M.Rosinol, LauraMartinez, RafaelOriol, AlbertMartin, JesusGutierrez, Norma C.Belen Vidriales, MariaBlade, JoanJose Lahuerta, JuanMateos, Maria-VictoriaSan Miguel, Jesus
- [39] Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myelomaBLOOD ADVANCES, 2022, 6 (03) : 808 - 817Mohan, MeeraKendrick, SamanthaSzabo, AnikoYarlagadda, NaveenAtwal, DineshPandey, YadavRoy, AryaParikh, RichaLopez, JamesThanendrarajan, SharmilanSchinke, CarolinaAlapat, DaisySawyer, JeffreyTian, ErmingTricot, Guidovan Rhee, FritsZangari, Maurizio
- [40] Intestinal Microbiota Composition Is Associated with Minimal residual Disease Negativity in Patients with Multiple MyelomaBLOOD, 2018, 132Pianko, Matthew J.Devlin, Sean M.Littmann, Eric R.Chansakul, AisaraMastey, DonnaSalcedo, MeghanFontana, EmilyLing, LilanTavitian, ElizabetSlingerland, John B.Slingerland, Ann E.Clurman, AnnelieGomes, Antonio L. C.Taur, YingPamer, Eric G.Peled, Jonathan U.van den Brink, Marcel R. M.Landgren, OlaLesokhin, Alexander M.